Helicase Capital

Helicase Capital is a general partnership founded in 2018 by undergraduate students at Harvard and Tufts. The fund's focus is finding undervalued clinical stage biotech companies. Pitches are given by partners and voted on at fund meetings. The management team is in charge of meetings, bookkeeping, and portfolio management. We utilize our scientific expertise to evaluate the drug development and clinical landscape of the assets encapsulated in potential investments. Our portfolio is made up of publicly-traded biotechnology companies.

所属行业

投资管理

规模

11-50 人

总部

Cambridge，Massachusetts

类型

合营企业

创立

2018

领域

Biotechnology、Therapeutics、Investment、Healthcare和Life Sciences